Guangzhou Lupeng Pharmaceutical Company Ltd.

This first-in-human study tested a new oral medication called LP-118 in patients with advanced cancers that had stopped responding to other treatments. The main goals were to find a safe dose, see how the body processes the drug, and check for early signs that it might help contr…